Indonesia Healthcare Market has been driven by Increase in Foreign Direct Investment and favourable Government Initiatives: Ken Research

1
Indonesia Healthcare Market has been driven by
Increase in Foreign Direct Investment and
favourable Government Initiatives Ken Research
2
Implementation of JKN (National Health Insurance
System) by the government, growing foreign
investment in the private hospital sector,
expansion of service and product portfolio by
major private hospital chains and pharmaceutical
companies were the key factors driving growth in
Indonesia Healthcare Market.
3

• The Indonesia healthcare market has shown a
  positive incline during 2012-2017 but with
  respect to the expanding population of Indonesia,
  the market is still underserved especially in the
  underdeveloped and rural areas as of 2017.
• The implementation of JKN scheme by the
  government has led to rise in demand for primary
  healthcare facilities and increased generic drug
  sale. This has further led to increase in number
  of outpatients and improvement in margins mainly
  from upgrades for standard JKN fees and services.
• The industry has undergone various deregulation
  programs which has encouraged foreign investment
  in the industry. For instance, the government
  removed pharmaceutical industry from its negative
  investment list implying 100 foreign ownership
  is allowed. Further, foreign players are allowed
  to hold 67 stake in both general and specialty
  hospitals. Foreign investors such as
  Malaysia-based Creador

4

• injected USD 45 million in Medikaloka Hermina,
  the operator of the Hermina Hospital Group.
  Netherlands has accounted for the largest share
  of USD 10 million in the total foreign investment
  of USD 14.3 million during the first half of
  2017.
• The market has witnessed enhancing innovation in
  nutritional health segment and biopharmaceuticals
  due to growing prevalence of lifestyle diseases
  such as diabetes, hypertension and obesity.
  International companies have benefitted from
  rising demand in medication for chronic diseases
  such as Tuberculosis, HIV and others.
  Furthermore, increase in demand for generic
  medicines has led the major players in the
  industry to expand their production capabilities.
  In order to capture the market potential, the
  industry has observed various mergers and
  acquisitions over the last few years. Further,
  there are startups such as PesanLab which offers
  a booking service for laboratory testing, or
  Homecare24 which offers

5

• on-demand home care services. This will further
  lead to integration of healthcare services in the
  country.
• The report titled Indonesia Healthcare Market
  Outlook to 2022 - by Hospitals, Clinical
  Laboratories, Pharmaceutical, Pharmacy Chains,
  Medical Device Segment by Ken Research suggested
  a growth at a CAGR of 9.6 in revenue in
  Indonesia Healthcare Market by 2022.
• Key Topics Covered in the Report
• Medical Devices Market Indonesia
• Indonesia Healthcare Statistics
• Diabetes Prevalence Indonesia
• Pharmaceutical Market Indonesia
• Obese Population Indonesia
• Number of Hospitals Indonesia
• Healthcare Spending Indonesia
• Number of Puskesmas Indonesia

6
Medical Device Imports Indonesia Type of Medical
Devices Indonesia Tuberculosis Prevalence
Indonesia For more information on the research
report, refer to below link https//www.kenresear
ch.com/healthcare/general-healthcare/indonesia-hea
lthcare-market/143541-91.html Related Reports by
Ken Research https//www.kenresearch.com/healthcar
e/general-healthcare/saudi-arabia-healthcare-marke
t-research-report/1106-91.html https//www.kenres
earch.com/healthcare/general-healthcare/uae-health
care-market-report/37505-91.html
7
https//www.kenresearch.com/healthcare/general-hea
lthcare/qatar-healthcare-market-report/99730-91.ht
ml Contact Ken Research Ankur Gupta, Head
Marketing Communications sales_at_kenresearch.com
91-124-4230204